Ensysce Biosciences, Inc. (ENSC) Operating income 2018–2025
Ensysce Biosciences, Inc. (ENSC) annual operating income history from SEC filings — each fiscal year as reported.
-$10.2MFY2025 · since FY2018: -$959,240 → -$10.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.2M | -52.2% |
| FY2024 | -$6.7M | +37.2% |
| FY2023 | -$10.7M | +55.8% |
| FY2022 | -$24.2M | -21.9% |
| FY2021 | -$19.9M | -1131.7% |
| FY2020 | -$1.6M | +51.5% |
| FY2019 | -$3.3M | -247.0% |
| FY2018 | -$959,240 | — |
Source: SEC XBRL filings · For reference only · Not investment advice